FDA to Add Warning Label for Heart Inflammation on Pfizer’s Covid Vaccine

Mediaite

Published

The U.S. Food and Drug Administration said Wednesday it would add a new label on the Covid-19 vaccine developed by Pfizer/BioNTech warning that rare cases of heart inflammation could occur after taking the vaccine.

Full Article